- The Wall Street Journal•8 hours ago
While Brexit provided an expected boost to core earnings for GlaxoSmithKline, it also led to a big write-down—the latest in a series of surprises stemming from Britain’s vote to leave the EU.
|Bid||1,710.50 x 187100|
|Ask||1,711.00 x 336900|
|52wk Range||1,227.50 - 1,716.00|
|Day's Range||1,693.00 - 1,716.00|
|Avg Vol (3m)||8,643,769|
As of 7:56 AM EDT. LSE Delayed Price. Market open.